Uniunea Europeană -
română -
EMA (European Medicines Agency)
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lunsumio 1 mg
roche pharma ag - germania - mosunetuzumabum - conc. pt. sol. perf. - 1mg - anticorpi monoclonali si conjugati
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lunsumio 30 mg
roche pharma ag - germania - mosunetuzumabum - conc. pt. sol. perf. - 30mg - anticorpi monoclonali si conjugati